Whole-body MRI for people with no symptoms: what the evidence shows
Whole-body MRI can detect abnormalities, but detection alone does not establish a health benefit. A source-based review of incidental findings, follow-up and uncertainty.
Screening
Screening modalities compared on what the evidence can actually tell you — detection, downstream testing, and the absence of mortality data.
The question screening has to answer
A screening test is not justified by the fact that it finds things. It is justified if finding those things earlier changes outcomes for the people screened. That is a harder test than it sounds, and requires evidence for the particular test and population.
Two numbers matter, and they are usually reported separately when they should be reported together:
- How often something is found.
- What happens next, and whether it helps.
A test that finds abnormalities in most people and helps a small fraction is not self-evidently a good test. The downstream costs — additional imaging, biopsies, anxiety, and treatment of findings that would never have caused harm — fall on everyone, while the benefit falls on a few.
Start with the purpose
Screening before symptoms and investigation of an existing concern are different tasks. Ask which task a proposed test serves, what evidence applies to your risk group and whether the result would change care. Our whole-body MRI review considers general screening rather than diagnostic imaging.
What to ask before any screening
- What is the detection rate, and what proportion of detections turn out to be nothing?
- What proportion of people need further tests afterwards?
- Is there any evidence that this reduces mortality, or only that it finds things?
- How often does it produce a false negative, and what does a normal result actually rule out?
- What is the follow-up plan for an indeterminate finding, and who pays for it?